Computational Approaches for the Structure-Based Identification of Novel Inhibitors Targeting Nucleoid-Associated Proteins in Mycobacterium Tuberculosis
Authors:
- 13 March 2023
- journal article
- research article
- Published by Springer Nature in Molecular Biotechnology
- Vol. 66 (4) , 814-823
Abstract
Implementation of computational tools in the identification of novel drug targets for Tuberculosis (TB) has been a promising area of research. TB has been a chronic infectious disease caused by Mycobacterium tuberculosis (Mtb) localized primarily on the lungs and it has been one of the most successful pathogen in the history of mankind. Extensively arising drug resistivity in TB has made it a global challenge and need for new drugs has become utmost important.The involvement of Nucleoid-Associated Proteins (NAPs) in maintaining the structure of the genomic material and regulating various cellular processes like transcription, DNA replication, repair and recombination makes significant, has opened a new arena to find the drugs targeting Mtb. The current study aims to identify potential inhibitors of NAPs through a computational approach. In the present work we worked on the eight NAPs of Mtb, namely, Lsr2, EspR, HupB, HNS, NapA, mIHF and NapM. The structural modelling and analysis of these NAPs were carried out. Moreover, molecular interaction were checked and binding energy was identified for 2500 FDA-approved drugs that were selected for antagonist analysis to choose novel inhibitors targeting NAPs of Mtb. Drugs including Amikacin, streptomycin, kanamycin, and isoniazid along with eight FDA-approved molecules that were found to be potential novel targets for these mycobacterial NAPs and have an impact on their functions. The potentiality of several anti-tubercular drugs as therapeutic agents identified through computational modelling and simulation unlocks a new gateway for accomplishing the goal to treat TB. Graphical Abstract Complete framework of the methodology employed in this study to predict inhibitors against mycobacterial NAPs.Keywords
This publication has 56 references indexed in Scilit:
- Efflux pump inhibitors: targeting mycobacterial efflux systems to enhance TB therapyJournal of Antimicrobial Chemotherapy, 2015
- Zafirlukast Inhibits Complexation of Lsr2 with DNA and Growth of Mycobacterium tuberculosisAntimicrobial Agents and Chemotherapy, 2013
- A novel nucleoid-associated protein specific to the actinobacteriaNucleic Acids Research, 2013
- Virulence Regulator EspR of Mycobacterium tuberculosis Is a Nucleoid-Associated ProteinPLOS Pathogens, 2012
- Open Babel: An open chemical toolboxJournal of Cheminformatics, 2011
- Immunoinformatics: Current trends and future directionsDrug Discovery Today, 2009
- A novel nucleoid-associated protein of Mycobacterium tuberculosis is a sequence homolog of GroELNucleic Acids Research, 2009
- Automated comparative protein structure modeling with SWISS‐MODEL and Swiss‐PdbViewer: A historical perspectiveElectrophoresis, 2009
- ProSA-web: interactive web service for the recognition of errors in three-dimensional structures of proteinsNucleic Acids Research, 2007
- SWISS-MODEL: an automated protein homology-modeling serverNucleic Acids Research, 2003